25th Mar 2014 13:12
LONDON (Alliance News) - Epistem Holdings PLC Tuesday posted a widened pretax loss as it saw revenue decline in the half-year ended December 31, 2013, and it upped its investment in the development of its Genedrive product. Genedrive is a molecular diagnostic technology. Epistem poste Read More